U.S. flag

An official website of the United States government

NM_000383.4(AIRE):c.1322C>T (p.Thr441Met) AND not specified

Germline classification:
Conflicting interpretations of pathogenicity (2 submissions)
Last evaluated:
Sep 1, 2023
Review status:
criteria provided, conflicting classifications
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000503763.11

Allele description [Variation Report for NM_000383.4(AIRE):c.1322C>T (p.Thr441Met)]

NM_000383.4(AIRE):c.1322C>T (p.Thr441Met)

Gene:
AIRE:autoimmune regulator [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
21q22.3
Genomic location:
Preferred name:
NM_000383.4(AIRE):c.1322C>T (p.Thr441Met)
HGVS:
  • NC_000021.9:g.44293832C>T
  • NG_009556.1:g.12953C>T
  • NM_000383.4:c.1322C>TMANE SELECT
  • NP_000374.1:p.Thr441Met
  • LRG_18t1:c.1322C>T
  • LRG_18:g.12953C>T
  • NC_000021.8:g.45713715C>T
  • NM_000383.2:c.1322C>T
  • NM_000383.3:c.1322C>T
Protein change:
T441M
Links:
dbSNP: rs72650677
NCBI 1000 Genomes Browser:
rs72650677
Molecular consequence:
  • NM_000383.4:c.1322C>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000051954Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Likely benign
(Sep 1, 2023)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Citation Link,

SCV000593079Genetic Services Laboratory, University of Chicago
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Nov 7, 2016)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenonot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

AIRE gene polymorphisms in systemic sclerosis associated with autoimmune thyroiditis.

Ferrera F, Rizzi M, Sprecacenere B, Balestra P, Sessarego M, Di Carlo A, Filaci G, Gabrielli A, Ravazzolo R, Indiveri F.

Clin Immunol. 2007 Jan;122(1):13-7. Epub 2006 Nov 13.

PubMed [citation]
PMID:
17101293

Targeted high-throughput sequencing technique for the molecular diagnosis of primary immunodeficiency disorders.

Chi ZH, Wei W, Bu DF, Li HH, Ding F, Zhu P.

Medicine (Baltimore). 2018 Oct;97(40):e12695. doi: 10.1097/MD.0000000000012695.

PubMed [citation]
PMID:
30290665
PMCID:
PMC6200533
See all PubMed Citations (4)

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV000051954.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

Variant summary: AIRE c.1322C>T (p.Thr441Met) results in a non-conservative amino acid change located in the Zinc finger, PHD-type domain of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0014 in 269480 control chromosomes, including one homozygote, predominantly at a frequency of 0.0035 within the Ashkenazi Jewish subpopulation in the gnomAD database. The observed variant frequency within Ashkenazi Jewish control individuals in the gnomAD database is approximately 1.3 fold of the estimated maximal expected allele frequency for a pathogenic variant in AIRE causing Autoimmune Polyglandular Syndrome Type 1 phenotype (0.0028), while, the frequency within South Asian control individuals is equal to the estimated maximal expected allele frequency for a pathogenic variant; these data suggesting that the variant is a benign polymorphism. c.1322C>T has been reported in the literature in individuals affected with Addison disease, primary immunodeficiency disease and autoimmune thyroiditis, Sjogren syndrome and mendelian susceptibility to mycobacterial diseases (Chi_2018, Ferrera_2007, Mazza_unpublished abstract_2006. Suratannon_2020). These reports do not provide unequivocal conclusions about association of the variant with Autoimmune Polyglandular Syndrome Type 1. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 17101293, No_PMID, 30290665, 32373116). Five ClinVar submitters (evaluation after 2014) cite the variant as uncertain significance (n=4) and benign (n=1). Based on the evidence outlined above, the variant was classified as likely benign.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Genetic Services Laboratory, University of Chicago, SCV000593079.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenonot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 15, 2024